Background In the post–COVID-19 pandemic era, many countries have launched apps to trace contacts of COVID-19 infections. Each contact-tracing app (CTA) faces a variety of issues owing to different national policies or technologies for tracing contacts. Objective In this study, we aimed to investigate all the CTAs used to trace contacts in various countries worldwide, including the technology used by each CTA, the availability of knowledge about the CTA from official websites, the interoperability of CTAs in various countries, and the infection detection rates and policies of the specific country that launched the CTA, and to summarize the current problems of the apps based on the information collected. Methods We investigated CTAs launched in all countries through Google, Google Scholar, and PubMed. We experimented with all apps that could be installed and compiled information about apps that could not be installed or used by consulting official websites and previous literature. We compared the information collected by us on CTAs with relevant previous literature to understand and analyze the data. Results After screening 166 COVID-19 apps developed in 197 countries worldwide, we selected 98 (59%) apps from 95 (48.2%) countries, of which 63 (66.3%) apps were usable. The methods of contact tracing are divided into 3 main categories: Bluetooth, geolocation, and QR codes. At the technical level, CTAs face 3 major problems. First, the distance and time for Bluetooth- and geolocation-based CTAs to record contact are generally set to 2 meters and 15 minutes; however, this distance should be lengthened, and the time should be shortened for more infectious variants. Second, Bluetooth- or geolocation-based CTAs also face the problem of lack of accuracy. For example, individuals in 2 adjacent vehicles during traffic jams may be at a distance of ≤2 meters to make the CTA trace contact, but the 2 users may actually be separated by car doors, which could prevent transmission and infection. In addition, we investigated infection detection rates in 33 countries, 16 (48.5%) of which had significantly low infection detection rates, wherein CTAs could have lacked effectiveness in reducing virus propagation. Regarding policy, CTAs in most countries can only be used in their own countries and lack interoperability among other countries. In addition, 7 countries have already discontinued CTAs, but we believe that it was too early to discontinue them. Regarding user acceptance, 28.6% (28/98) of CTAs had no official source of information that could reduce user acceptance. Conclusions We surveyed all CTAs worldwide, identified their technological policy and acceptance issues, and provided solutions for each of the issues we identified. This study aimed to provide useful guidance and suggestions for updating the existing CTAs and the subsequent development of new CTAs.
BACKGROUND Background In the post-coronavirus disease (COVID-19) pandemic era, many countries launched apps to trace contacts of COVID-19 infections. Each contact tracing application (CTA) faces a variety of issues owing to different national policies or technologies to trace contacts. OBJECTIVE Objective We aimed to investigate all CTAs used to trace contacts in various countries worldwide, including the technology used by each CTA, the availability of knowledge information from official websites, the interoperability of the CTAs in various countries, the infection detection rate and policies of the specific country, and to summarize the current problems of the application based on the information collected. METHODS Method We investigated CTAs launched in all countries through Google, Google Scholar, and PUBMED. After eliminating CTAs that did not meet the screening criteria, we experimented with all applications that could be installed and complemented with information about applications that could not be installed or used by consulting official websites and previous literature. We compared the collected information on CTAs with relevant previous literature to understand and analyze the data. RESULTS Result After screening 166 COVID-19 applications developed in 197 countries worldwide, we selected 98 applications from 95 countries, among these, 63 apps were usable. The methods of contact tracing are divided into three main categories: Bluetooth, geolocation, and QR codes. Each method is further categorized depending on the protocol. At the effectiveness level, CTAs face three problems. First, the distance and time for Bluetooth/geolocation-based CTAs to record contact are generally set to 2m/15min; however, this distance should be lengthened and the time should be shortened for more infectious variants. Second, Bluetooth/geolocation-based CTAs also face the problem of lack of accuracy, for which the ultrasonic technology adopted by CTA of United states (NOVID) has proven to be effective in improving the accuracy of CTA. Additionally, we investigated infection detection rates in 33 countries, 16 of which had significantly low detection rates and wherein CTAs could have lacked effectiveness in reducing virus propagation. Regarding policy, CTAs in all countries (except for that in Europe) can only be used in their own countries and lack interoperability among others countries. In addition, five countries have already discontinued CTAs, but we believe that it is too early to discontinue them. With regard to the user acceptance, 28 out of 98 CTAs had no official source of knowledge, which could reduce user acceptance of CTAs. CONCLUSIONS Conclusion We surveyed all CTAs worldwide and identified their technical, effectiveness, policy, and acceptance issues in the post-COVID-19 pandemic era.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.